February 20-21, 2023 | Paris, France
15^th International Conference on Vascular Dementia
https://vasculardementia.conferenceseries.com/

With the positive response and feedback we received from Vascular Dementia 2022 participants and supporters, we are pleased to announce our upcoming conferences in the Series, the "15th International Conference on Vascular Dementia," which will be held on February 20–21, 2023, in Paris, France, with the theme "Tackling Dementia with Technology". Vascular Dementia 2023 serves as an international forum for business delegates, B2B encounters poster presentations, workshops, symposia, and networking, and to thank the organizing committee, the keynote speakers, the plenary speakers, the chairs and co-chairs, the young researchers, and other participants whose contributions helped to make the conference a great success. It will provide a platform where you may exhibit items and services to assure massive exposure and networking. Take advantage of the opportunity and present your original concepts, cutting-edge technology, and recent research.

Neurological problems affect hundreds of millions of individuals globally. Every year, more than 6 million people suffer from strokes; more than 80% of these fatalities occur in low- and middle-income nations. Epilepsy affects more than 50 million individuals globally. The number of people with dementia is estimated to be 47.5 million worldwide, with 7.7 million new cases occurring each year. Alzheimer's disease is the most common cause of dementia and may be to blame for 60-70% of cases. In the entire world, more than 10% of people have migraines. The global Dementia sickness market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of seventeen.5%, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics and about  Alzheimer's disease, is the commonest style of dementia.

Vascular dementia studies are used in the treatment of neurological disorders such as Alzheimer disease and other dementia, epilepsy, cerebrovascular diseases such as stroke, headache, and other migraine issue, Parkinson's disease, multiple sclerosis, neuro infection, brain tumors, horrific sensory system disarrays due to head injury, and neurological issue due to ill health. The many treatments used to treat various neurological problems are included in the study of vascular dementia and other neurological disorders. Innovative therapies for the treatment of neuro diseases are being developed by biopharmaceutical companies. Governmental entities support research and development efforts related to neurology analysis. Together with the rising prevalence of neurological illnesses, these factors are having a favorable effect on the market for neurology. Pharmacies were pursuing novel methods for the treatment of conditions related to neurology. The global market for neurology is expanding due to population growth, rising awareness of mental and neurological disorders, expanding insurance reforms, and ongoing research and development in neurology by pharmaceutical companies.

Abstract Submission Link:
Abstract Submission Deadline: Nov 30, 2022

For More Information contact the conference Manager ( Agatha Clemens) at dementia@meetingsnexpo.com or call us on Tel: +44- 7915638336